Table 1 Patient characteristics for all patients and for patients diagnosed with VTE and those with no VTE during the ICU stay
Variable | Total (n = 56) | No VTE (n = 48) | VTE (DVT ± PE; n = 3, PE n = 5) |
|---|---|---|---|
Age, years (SD) | 62.3 (13.5) | 61.6 (14.4) | 65.5 (3.6) |
Female sex n(%) | 13 (23) | 13 (27) | 0 (0) |
BMI, kg/m2 (IQR) | 29.0 (26.7–34.0) | 29.2 (26.6–34.1) | 28.5 (27.2–31.6) |
Hypertension n(%) | 29 (52) | 23 (48) | 6 (75) |
Pulmonary disease | |||
Asthma n(%) | 10 (18) | 9 (19) | 1 (13) |
COPD n(%) | 5 (8.9) | 5 (10) | 0 (0) |
Unspecified n(%) | 1 (1.8) | 1 (2.1) | 0 (0) |
Ischemic heart disease n(%) | 7 (13) | 6 (13) | 1 (13) |
History of VTE n(%) | 2 (3.6) | 1 (2.1) | 1 (13) |
Diabetes mellitus n(%) | 12 (21) | 10 (21) | 2 (25) |
Ongoing smoking n(%) | 4 (7.3) | 4 (8.5) | 0 (0) |
Previous smoking n(%) | 12 (22) | 10 (21) | 2 (25) |
Heart failure n(%) | 2 (3.6) | 2 (4.2) | 0 (0) |
Days from symptom onset at ICU admission, (IQR) | 10 (8–12) | 9 (8–11) | 10 (9–13) |
SAPS 3 score at ICU admission (SD) | 53 (10) | 53 (10) | 52 (8) |
Parenteral anticoagulation prior to DVT screening | |||
Prophylactic dose n(%) | 46 (82) | 43 (90) | 3 (38) |
Therapeutic dose n(%) | 5 (8.9) | 0 (0) | 5 (63) |